Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Therapy of Relapsed Hodgkin Lymphoma
Amanda F. Cashen
,
Nancy L. Bartlett
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Section of Medical Oncology
Section of Bone Marrow Transplant & Leukemia
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapy of Relapsed Hodgkin Lymphoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Relapsed Lymphoma
100%
Hodgkin Lymphoma
66%
Chemosensitive
33%
Monoclonal Antibody
33%
Standard of Care
33%
Gemcitabine
33%
Rituximab
33%
Treatment-related Mortality
33%
Randomized Clinical Trial
33%
Optimal Therapy
33%
Long-term Disease-free Survival
33%
CD30
33%
Primary Chemotherapy
33%
Reduced Intensity Transplantation
33%
Salvage Regimen
33%
Chemorefractory Disease
33%
Vinorelbine
33%
Medicine and Dentistry
Hodgkin's Lymphoma
100%
Autologous Stem Cell Transplantation
75%
Monoclonal Antibody
25%
Rituximab
25%
Disease Free Survival
25%
Randomized Clinical Trial
25%
Allogeneic Stem Cell Transplantation
25%
Gemcitabine
25%
Vinorelbine
25%
Diseases
25%